Home/Filings/4/0001193125-25-285057
4//SEC Filing

Assis Alessandra Faccin 4

Accession 0001193125-25-285057

CIK 0001674862other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 9:37 PM ET

Size

8.9 KB

Accession

0001193125-25-285057

Insider Transaction Report

Form 4
Period: 2025-11-13
Assis Alessandra Faccin
SVP and GM, Life Sciences
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-13$53.10/sh+1,340$71,1546,286 total
  • Tax Payment

    Common Stock

    2025-11-13$53.10/sh570$30,2675,716 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-11-131,3402,680 total
    Common Stock (1,340 underlying)
Footnotes (4)
  • [F1]Payment of tax liability by withholding securities incident to the vesting of Restricted Stock Units acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3.
  • [F2]Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.
  • [F3]Grant of Restricted Stock Units pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant vest in three equal installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer.
  • [F4]Balance includes additional restricted stock units acquired in lieu of cash dividends.

Documents

1 file

Issuer

ASHLAND INC.

CIK 0001674862

Entity typeother

Related Parties

1
  • filerCIK 0001931500

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 9:37 PM ET
Size
8.9 KB